Literature DB >> 7394691

Antibodies to Chlamydia trachomatis in cervicovaginal secretions: relation to serum antibodies and current chlamydial infection.

S J Richmond, J D Milne, A L Hilton, E O Caul.   

Abstract

Concentrated cervicovaginal washings obtained from women attending a venereal disease clinic were tested for Chlamydia-specific immunoglobulins by means of a single-antigen, indirect immunofluorescence technique. Chlamydial antibodies (IgA and/or IgG) were present in washings from 22 (42%) of 52 patients tested. These Chlamydia-specific antibodies were significantly (P less than 0.001) associated with Chlamydia-specific antibodies in serum, which suggests that the former antibodies may have been derived from the serum rather than synthesized in the cervix. The association between chlamydial antibodies in cervicovaginal washings and isolation of Chlamydia from the cervix was much weaker. These results indicate that the diagnostic value of detection of Chlamydia-specific antibodies in sera and in cervical secretions is questionable.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7394691     DOI: 10.1097/00007435-198001000-00003

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

1.  Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Authors:  Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal
Journal:  Contraception       Date:  2011-03-23       Impact factor: 3.375

2.  Protective role of serum antibody in immunity to chlamydial genital infection.

Authors:  R G Rank; B E Batteiger
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  Persistence of chlamydial antibodies after pelvic inflammatory disease.

Authors:  M Puolakkainen; E Vesterinen; E Purola; P Saikku; J Paavonen
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

4.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar).

Authors:  A L Barron; R G Rank; E B Moses
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

6.  Surface expression of secretory component and HLA class II DR antigen on glandular epithelial cells from human endometrium and two endometrial adenocarcinoma cell lines.

Authors:  A C Menge; J Mestecky
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

7.  Comparison between cell culture and serology for detecting Chlamydia trachomatis in women seeking abortion.

Authors:  P A Csángó; B Sarov; H Schiøtz; I Sarov
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

8.  Diagnostic efficacy of chlamydial antibodies in cervical secretions from pregnant women and adolescent girls.

Authors:  H Thejls; V A Rahm; J Gnarpe; H Gnarpe
Journal:  Genitourin Med       Date:  1995-12

9.  Diagnosis of Chlamydia trachomatis infection--culture versus serology.

Authors:  E Schoenwald; B L Schmidt; G Steinmetz; J Hosmann; G Pohla-Gubo; A Luger; G Gasser
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

10.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.

Authors:  K H Ramsey; L S Soderberg; R G Rank
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.